Clinical Trial: FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects
Study Status: Completed
Recruit Status: RECRUITING
Condition: Healthy Volunteers
Study Type: INTERVENTIONAL
Official Title: Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Single- and Multiple-Ascending Doses of Intravenous ANT3310 Alone and in Combinat
Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of single and multiple intravenous ascending doses of ANT3310, a novel, specific, competitive inhibitor of serine ?-lactamases, alone and in combination with meropenem in healthy subjects.
Read more